Dorsey Wright & Associates Dr Reddys Laboratories LTD Transaction History

Dorsey Wright & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$57.98 - $73.08 $3.64 Million - $4.59 Million	-62,828 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$62.61 - $71.29 $74,130 - $84,407	-1,184 Reduced 1.85%	62,828 $4.48 Million
Q3 2020 Oct 28, 2020	BUY	$51.39 - $72.41 $38,079 - $53,655	741 Added 1.17%	64,012 $4.45 Million
Q2 2020 Jul 23, 2020	SELL	$39.55 - $54.65 $215,824 - $298,225	-5,457 Reduced 7.94%	63,271 $3.33 Million
Q1 2020 Apr 20, 2020	SELL	$34.75 - $45.85 $272,579 - $359,647	-7,844 Reduced 10.24%	68,728 $2.77 Million

Q4 2019 Jan 31, 2020	SELL	$36.66 - $41.78 $116,725 - $133,027	-3,184 Reduced 3.99%	76,572 $3.11 Million
Q3 2019 Oct 31, 2019	SELL	$34.82 - $39.26 $39,973 - $45,070	-1,148 Reduced 1.42%	79,756 $3.02 Million
Q2 2019 Jul 02, 2019	BUY	$36.05 - $42.76 $2.92 Million - $3.46 Million	80,904 New	80,904 $3.03 Million

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.